The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
9 reports and counting
Bayer Raises $60B in Public
Bayer, a Pharmaceuticals company based in Kaiser-Wilhelm-Allee 1, Leverkusen 51373, Germany, has raised $60B in Public at a $65B valuation led by Public.
Bayer raises $60B Public at $65B valuation
Bayer raises $60B in Public at $65B valuation. Pharmaceutical and life sciences company...
Bayer Headquarters - Office Location & Address
Discover Bayer's headquarters at Kaiser-Wilhelm-Allee 1, Leverkusen 51373. Pharmaceutical and life sciences company. Learn about the office facilities and work environment.
Bayer US Headquarters - Office Location & Address
Discover Bayer US's headquarters at 100 Bayer Blvd, Whippany, NJ 07981. Pharmaceutical and life sciences company. Learn about the office facilities and work environment.
Bayer AG Headquarters - Office Location & Address
Discover Bayer AG's headquarters at 51368 Leverkusen, Leverkusen, 51368. Pharmaceutical and life sciences company. Learn about the office facilities and work environment.
Bayer Crop Science Headquarters - Office Location & Address
Discover Bayer Crop Science's headquarters at Alfred-Nobel-Strasse 50, Monheim, 40789. Crop protection and seeds. Learn about the office facilities and work environment.
CRISPR Therapeutics Raises $337M in Follow-on Offering
CRISPR Therapeutics, a Biotech company based in Aeschenvorstadt 36, Basel 4051, Switzerland, has raised $337M in Follow-on Offering at a $8B valuation led by Versant Ventures, Bayer, Vertex Pharmaceuticals.
Elanco Animal Health Headquarters - Office Location & Address
Discover Elanco Animal Health's headquarters at 2500 Innovation Way, Greenfield, IN 46140. Global animal health company developing products to prevent and treat disease in farm animals and pets. Provides pet and farm animal health products spun off from Eli Lilly, acquired Bayer Animal Health.. Learn about the office facilities and work environment.
CRISPR Therapeutics raises $337M Follow-on Offering at $8B valuation
CRISPR Therapeutics raises $337M in Follow-on Offering at $8B valuation. Gene-based medicines using CRISPR/Cas9...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.